A Phase I Trial of 90Y-BC8-DOTA (Anti-CD45) Monoclonal Antibody in Combination with Fludarabine and TBI As Conditioning for Allogeneic Peripheral Blood Stem Cell Transplant to Treat High Risk Multiple Myeloma
| Autor: | Tuazon, Sherilyn A, Sandmaier, Brenda M., Orozco, Johnnie J., Gopal, Ajay K., Holmberg, Leona A., Becker, Pamela S., Lundberg, Sally J. *, Till, Brian G., Nartea, Margaret E. *, Gooley, Ted *, Fisher, Darrell R. *, Rajendran, Joseph G. *, Press, Oliver W., Bensinger, William I. *, Green, Damian J. |
|---|---|
| Zdroj: | In Blood 8 December 2017 130 Supplement 1:910-910 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|